# Hydroxyproline Influence on Oxalate Metabolism

> **NCT02038543** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 22 (actual)

## Conditions studied

- Hyperoxaluria

## Interventions

- **DRUG:** Hydroxyproline and Leucine

## Key facts

- **NCT ID:** NCT02038543
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-09
- **Final completion:** 2017-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02038543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02038543, "Hydroxyproline Influence on Oxalate Metabolism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02038543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*